Scancell (LON:SCLP) Shares Up 6.9% – What’s Next?

Shares of Scancell Holdings plc (LON:SCLP) were up 6.9% during mid-day trading on Wednesday . The stock traded as high as GBX 15.30 ($0.19) and last traded at GBX 13.90 ($0.18). Approximately 3,173,671 shares were traded during trading, an increase of 366% from the average daily volume of 680,913 shares. The stock had previously closed at GBX 13 ($0.16).

Scancell Trading Up 7.5 %

The company has a debt-to-equity ratio of 61.41, a current ratio of 3.42 and a quick ratio of 13.01. The company has a market cap of £129.87 million, a price-to-earnings ratio of -1,385.00 and a beta of 0.35. The business’s fifty day moving average price is GBX 13.95 and its 200 day moving average price is GBX 13.59.

About Scancell

Scancell Holdings plc, a clinical stage biopharmaceutical company, engages in the discovery and development of novel immunotherapies and vaccines for the treatment of cancer and infectious disease. Its product candidates include SCIB1, an ImmunoBody cancer vaccine that is in Phase II for the treatment of metastatic melanoma; and SCIB2/iSCIB2 vaccine, which is under evaluation for the treatment of patients with solid tumors, including non-small cell lung cancer.